one
import
pursuit
scienc
engin
research
today
develop
lowcost
userfriendli
technolog
improv
health
peopl
past
decad
research
effort
microfluid
made
develop
method
facilit
lowcost
diagnosi
infecti
diseas
especi
resourcepoor
set
provid
overview
recent
advanc
microfluid
devic
pointofcar
poc
diagnost
infecti
diseas
emphasi
place
malaria
sepsi
aidshiv
infecti
diseas
sar
tuberculosi
dengu
also
briefli
discuss
infecti
diseas
chosen
contribut
disabilityadjust
lifeyear
dali
lost
accord
world
health
organ
current
state
research
area
evalu
project
toward
futur
applic
accompani
challeng
also
discuss
malaria
infect
plasmodium
protozoa
intermedi
host
anophel
mosquito
current
common
gardner
et
al
infect
red
blood
cell
irbc
disrupt
microcircul
maier
et
al
manifest
anemia
organ
dondorp
et
al
failur
sever
case
despit
improv
malaria
manag
peopl
continu
fall
victim
diseas
annual
world
health
organ
gold
standard
test
malaria
microscop
method
thin
thick
giemsablood
smear
allow
train
technician
detect
parasitemia
level
irbc
cell
murray
et
al
although
test
one
afford
mean
malaria
diagnosi
specif
reli
critic
qualiti
microscop
skill
technician
misinterpret
microorgan
like
bacteria
fungi
plasmodium
protozoa
difficulti
differenti
differ
plasmodium
strain
erdman
kain
logist
challeng
transport
microscop
remot
area
may
also
delay
diagnost
effort
gascoyn
et
al
anoth
import
malaria
diagnost
tool
rapid
diagnost
test
rdt
detect
malaria
antigen
usual
blood
monoclon
antibodi
specif
target
parasit
antigen
rdt
circumv
challeng
poor
road
electr
infrastructur
remot
area
result
obtain
min
via
simpl
selftest
interpret
mill
et
al
nonetheless
humid
warm
climat
degrad
chemic
adsorb
onto
rdt
chiodini
et
al
rdt
detect
plasmodium
falciparum
target
histidinerich
protein
bell
et
al
plasmodium
protein
lactat
dehydrogenas
iqbal
et
al
henc
rdt
result
may
suffici
specif
guid
treatment
mix
infect
occur
abil
differenti
strain
malaria
parasit
infect
crucial
light
increas
evid
mix
infect
fatal
genton
et
al
infect
plasmodium
vivax
lethal
young
children
tjitra
et
al
emerg
artemisininresist
p
falciparum
dondorp
et
al
sensit
rdt
also
declin
parasitemia
fall
mill
et
al
price
rdt
stand
us
depend
manufactur
order
quantiti
also
prohibit
resourcescarc
commun
wongsrichanalai
et
al
laboratori
altern
polymeras
chain
reaction
pcr
also
use
diagnos
malaria
capabl
detect
low
parasitemia
level
mix
infect
makler
et
al
unfortun
accuraci
pcr
result
subject
suitabl
primer
sampl
collect
storag
transport
procedur
nucleic
acid
extract
protocol
furthermor
suscept
sampl
reagent
contamin
logist
transport
sampl
distant
laboratori
discourag
routin
use
pcr
malaria
diagnosi
tool
incompat
immedi
patient
care
grobusch
one
techniqu
malaria
diagnosi
hemozin
detect
hemozin
convert
malaria
parasit
degrad
product
hemoglobin
heme
heme
visual
polar
andor
dark
field
microscopi
howev
sensit
heme
detect
depend
strongli
parasitemia
level
amount
heme
present
rebelo
et
al
thu
techniqu
may
suitabl
detect
ring
trophozoit
stage
malaria
fig
summar
strength
weak
variou
malaria
diagnost
tool
avail
market
predomin
method
malaria
diagnosi
symptombas
arguabl
ineffect
malaria
share
mani
clinic
symptom
fever
povertyassoci
febril
ill
bell
et
al
bell
colleagu
propos
adopt
parasitebas
diagnosi
earli
diagnosi
treatment
could
allow
formal
health
servic
villag
level
reduc
morbid
mortal
costeffect
manner
ghebreyesu
et
al
microfluid
sar
outbreak
asianpacif
countri
infecti
diseas
experi
steadi
rise
number
public
hivaid
sepsi
affect
develop
develop
nation
equal
hand
number
public
malaria
tuberculosi
stagnat
despit
continu
need
better
diagnost
tool
resourcescarc
commun
show
diseas
preval
develop
nation
still
much
neglect
scientif
commun
concentr
develop
nation
regrett
mani
public
dengu
also
group
latin
america
southeast
asia
highlight
lack
intern
interest
infecti
diseas
note
public
number
calcul
use
pubm
sciencedirect
diagnost
platform
especi
use
facilit
parasitebas
prevent
diagnost
afford
manner
potenti
bridg
healthcar
gap
improv
malaria
manag
addit
earli
stage
malaria
parasitemia
level
may
low
beyond
accur
detect
limit
giemsa
smear
rdt
pcr
therefor
microfluid
techniqu
use
direct
diagnost
process
step
remov
interf
blood
cell
concentr
malaria
parasit
enhanc
sensit
test
erythrocyt
normal
averag
diamet
must
deform
consider
travers
capillari
significantli
smaller
diamet
alizadehrad
et
al
irbc
becom
progress
less
deform
parasit
matur
cranston
et
al
mark
decreas
membran
flexibl
attribut
two
main
factor
firstli
rel
nondeform
parasit
matur
trophozit
schizont
stage
caus
intern
viscos
rbc
increas
sharpli
quinn
et
al
secondli
membran
rigid
attribut
export
neoantigen
surfac
rbc
parasit
exert
oxid
stress
host
rbc
becker
et
al
increas
deform
precipit
import
pathophysiolog
outcom
reduct
flow
veloc
mcwhirter
et
al
increas
adher
vasculatur
channel
clog
thick
cellfre
layer
yin
et
al
base
knowledg
hou
et
al
investig
use
deform
biomark
onsit
irbc
enrich
use
inerti
microfluid
fig
team
exploit
margin
phenomenon
isol
irbc
found
increas
hematocrit
irbc
trophozoit
schizont
stage
displac
side
channel
demonstr
import
cellcel
interact
observ
margin
howev
maximum
flow
rate
platform
could
differenti
differ
speci
plasmodium
protozoa
furthermor
rbc
deform
also
characterist
diseas
sickl
cell
anemia
improv
specif
warrant
geisling
colleagu
also
enrich
less
deform
ringstag
irbc
averag
enrich
factor
throughput
cellsh
base
separ
process
driven
noninerti
lift
effect
geisling
et
al
warkiani
et
al
made
use
neg
deplet
approach
remov
leukocyt
lyse
blood
also
use
inerti
focus
warkiani
et
al
approxim
parasit
releas
irbc
could
captur
identifi
use
quantit
q
pcr
leukocyt
deplet
devic
also
boost
sensit
better
current
sensit
rdt
devic
coupl
diagnost
method
form
integr
platform
enrich
malaria
parasit
facilit
sensit
detect
bow
et
al
coupl
irbc
deform
fluoresc
measur
relat
mechan
properti
irbc
biochem
properti
bow
et
al
team
discov
geometri
constrict
affect
rbc
transit
time
geometri
sharper
corner
better
differenti
rbc
differ
deform
given
pressur
differ
microfluid
devic
also
demonstr
likelihood
rigid
ring
stage
p
falciparum
irbc
overlap
older
healthi
rbc
valid
concern
use
rbc
deform
biomark
fig
framework
evalu
suitabl
differ
malaria
diagnost
tool
market
first
criteria
adapt
assur
martinez
et
al
rest
adapt
gascoyn
et
al
microtot
analysi
system
evalu
seen
microfluid
platform
perform
par
even
superior
mani
exist
malaria
diagnost
note
afford
calcul
without
consid
fix
cost
machin
guo
colleagu
capit
differ
pressur
threshold
attribut
deform
differ
healthi
rbc
irbc
pass
progress
narrow
constrict
studi
malaria
diseas
guo
et
al
previous
tomaiuolo
cowork
also
provid
descript
rbc
viscoelast
properti
shape
function
appli
pressur
schemat
illustr
work
principl
microfluid
devic
work
concept
margin
irbc
less
deform
healthi
rbc
displac
peripher
wall
collect
make
use
margin
phenomenon
earli
stage
irbc
late
stage
irbc
recov
reprint
permiss
hou
et
al
b
schemat
illustr
microfabr
deformabilitybas
flow
cytomet
measur
dynam
mechan
respons
rbc
experiment
result
ii
demonstr
measur
veloc
rbc
function
infect
state
rbc
infect
late
ring
stage
parasit
pressur
gradient
pa
reprint
permiss
bow
et
al
c
schemat
show
microfluid
techniqu
purif
nucleic
acid
irbc
use
isotachophoresi
itp
le
te
lead
trail
electrolyt
isotachophoresi
use
extract
dna
malaria
parasit
nucleic
acid
yield
maxim
use
counterflow
increas
focus
time
limit
detect
parasitesnl
achiev
reprint
permiss
marshal
et
al
schemat
show
work
mechan
paper
base
microfluid
devic
autom
stain
malaria
parasit
embed
microscopi
window
paper
cartridg
consist
thin
singl
cell
layer
thick
multipl
cell
layer
smear
blood
stain
acridin
orang
dye
cartridg
optic
examin
irbc
reprint
permiss
horn
et
al
e
schemat
labelfre
microfluid
devic
separ
irbc
base
paramagnet
characterist
presenc
paramagnet
hemozin
irbc
use
separ
irbc
healthi
rbc
base
differenti
later
migrat
magnet
field
gradient
collect
ringstag
irbc
low
hemozin
concentr
made
possibl
use
steep
magnet
gradient
reprint
permiss
nam
et
al
drop
use
microfluid
devic
tomaiuolo
et
al
guo
et
al
found
irbc
schizont
stage
typic
block
constrict
blockag
significantli
elev
deform
pressur
similar
result
found
shelbi
et
al
found
trophozoit
stage
irbc
experienc
difficulti
pass
constrict
schizont
stage
irbc
block
small
constrict
shelbi
et
al
use
microfluid
devic
guo
et
al
show
stiff
ring
trophozoit
schizont
stage
irbc
time
uninfect
rbc
result
differ
measur
use
optic
tweezer
valu
respect
hosseini
feng
discrep
membran
stiff
highlight
import
establish
standard
tool
measur
cellular
membran
properti
microfluid
devic
may
also
suitabl
adapt
studi
phenomena
pit
rbc
recoveri
travers
narrow
constrict
shown
flow
condit
healthi
rbc
becom
part
vascular
occlus
rather
wind
way
center
irbc
exit
constrict
shelbi
et
al
use
microfluid
devic
henc
limit
malaria
diagnosi
mimic
channel
blockag
differ
bifurc
test
clinic
use
therapi
transfus
riddl
et
al
also
drug
microfluid
platform
use
membran
deform
biomark
malaria
may
hold
great
promis
suitabl
arguabl
challeng
face
emerg
knowledg
malaria
report
deform
uninfect
rbc
reduc
case
sever
malaria
dondorp
et
al
exact
mechan
unknown
suggest
vitro
cultur
p
falciparum
produc
heatlabil
exoantigen
decreas
rbc
deform
naumann
et
al
damag
effect
lipid
peroxid
rbc
membran
flexibl
also
propos
explain
aforement
phenomenon
mohan
et
al
use
microfluid
also
provid
valuabl
insight
differ
p
falciparum
p
vivax
infect
rbc
handayani
et
al
construct
microfluid
devic
narrow
constrict
observ
contrast
p
falciparum
infect
rbc
p
vivax
infect
rbc
development
stage
abl
transvers
gap
smoothli
handayani
et
al
postul
increas
intern
viscos
p
vivax
infect
rbc
could
offset
increas
membran
deform
find
highlight
import
enhanc
knowledg
malaria
diseas
interact
malaria
parasit
rbc
host
greater
understand
malaria
biolog
deformabilitybas
diagnost
test
robustli
design
group
util
concept
relat
electr
imped
zheng
et
al
transit
time
rosenbluth
et
al
differenti
blood
cancer
cell
concept
may
extend
malaria
detect
provid
rbc
irbc
suffici
distinct
key
paramet
dielectrophoresi
refer
spatial
nonuniform
electr
field
either
due
direct
current
altern
current
also
util
malariarel
studi
diagnosi
dielectrophoret
dep
forc
gener
dielectr
particl
ie
polariz
electr
insul
cell
subject
direct
altern
electr
field
cell
move
direct
increas
electr
field
gradient
intens
behavior
call
posit
dep
convers
term
neg
dep
pethig
markx
reader
refer
pethig
mathemat
equat
govern
gener
dep
forc
spheric
nonspher
particl
pethig
dep
respons
cell
depend
composit
permeabl
capacit
conduct
conform
cell
membran
cell
differ
type
size
physiolog
state
differenti
isol
gascoyn
et
al
use
differ
media
frequenc
electr
field
gascoyn
et
al
demonstr
possibl
use
dep
isol
irbc
gascoyn
et
al
electr
conduct
irbc
significantli
higher
uninfect
rbc
aceti
et
al
attribut
membran
permeat
pathway
induc
malaria
parasit
depfieldflow
fraction
fff
microfluid
devic
observ
nucleat
blood
cell
remain
depfff
chamber
emerg
electr
field
turn
prevent
leukocyt
contamin
next
appli
certain
frequenc
electr
signal
khz
irbc
levit
strongli
uninfect
rbc
emerg
rapidli
depfff
chamber
consequ
initi
cell
isol
contain
plasimodium
protozoa
du
cowork
also
util
dep
stretch
character
differ
biophys
properti
healthi
infect
rbc
latter
found
expectedli
lower
stretch
ratio
due
rigid
membran
nonetheless
note
one
critic
challeng
dep
strong
size
depend
cell
exhibit
variat
may
interfer
celltyp
specif
differ
dep
particl
separ
conduct
media
extracellular
solut
could
also
lead
joul
heat
near
electrod
bubbl
gener
heatrel
cell
death
devic
also
incompat
diagnosi
geograph
remot
area
access
stabl
electr
pcr
extrem
use
molecular
biolog
tool
replic
dna
step
denatur
anneal
extens
specif
temperatur
million
copi
dna
gener
minut
quantiti
dna
fragment
convent
pcr
may
use
malaria
diagnosi
grobusch
due
time
lag
sampl
transport
sampl
process
result
dissemin
srinivasan
et
al
microfluid
pcr
may
prove
otherwis
microfluid
pcr
higher
sensit
convent
pcr
rubio
et
al
furthermor
faster
speed
adapt
portabl
microfluid
pcr
greatli
boost
use
resourcescarc
region
malaria
endem
wang
et
al
addit
microfluid
devic
requir
small
sampl
volum
high
surfac
area
volum
ratio
offer
higher
temperatur
transit
speed
uniform
heat
distribut
reaction
effici
two
main
approach
perform
microfluid
pcr
ie
stationari
continu
flow
park
et
al
former
pcr
mixtur
hous
one
unit
experi
temperatur
chang
pcr
cycl
method
requir
lower
sampl
volum
run
risk
longer
reaction
time
nonuniform
heat
cool
latter
method
prefix
temperatur
zone
pcr
mixtur
flow
one
unit
anoth
approach
howev
oper
fix
number
pcr
cycl
may
complex
fabric
result
bulki
devic
current
droplet
microfluid
pcr
also
test
tewhey
et
al
microfluid
pcr
readout
integr
electrochem
fluoresc
gel
electrophoresi
minim
loss
due
transfer
amplifi
nucleic
acid
contamin
park
et
al
zhang
et
al
park
et
al
done
excel
review
microfluid
pcr
reader
encourag
refer
remark
refer
better
technic
inform
subject
zhang
et
al
park
et
al
given
specif
primer
pcr
process
approach
appli
diagnos
infecti
diseas
long
suffici
genom
materi
extract
techniqu
describ
section
therefor
also
applic
infecti
diseas
gener
innov
microfluid
pcr
categor
prepcr
sampl
process
ii
pcrreaction
iii
postpcr
analysi
prepcr
step
includ
cell
separ
cell
concentr
cell
lysi
nucleic
acid
extract
step
necessari
overcom
pcr
inhibitor
present
sampl
reduc
background
due
larg
amount
hematolog
cell
blood
sampl
lim
et
al
also
sever
way
cell
lyse
perform
microfluid
devic
use
minison
nanofabr
shear
structur
di
carlo
et
al
store
chemic
like
deterg
kim
et
al
enzym
sethu
et
al
extern
appli
electr
field
lee
tai
although
mani
microfluid
pcr
technolog
mani
specif
target
malaria
diagnosi
marshal
colleagu
develop
microfluid
platform
fig
purifi
dna
releas
malaria
parasit
resid
irbc
isol
dna
compat
quantit
pcr
abl
offer
sensit
marshal
et
al
innov
use
coupl
downstream
microfluid
platform
creat
malaria
diagnosi
also
suggest
gascoyn
et
al
although
much
discuss
incorpor
concept
deform
pcr
comprehens
diagnosi
malaria
best
knowledg
system
probabl
still
development
phase
also
benefici
loop
medit
thermal
amplif
lamp
pcr
one
sensit
specif
pcr
method
hopkin
et
al
integr
portabl
microfluid
devic
also
stress
need
combin
innov
creat
differ
pcr
compon
creat
truli
function
prototyp
variou
improv
made
instanc
creation
microfluid
digit
recombinas
polymeras
amplif
rpa
slipchip
quantit
detect
dna
shen
et
al
amplif
one
step
pcr
technolog
facilit
better
mix
reagent
concentr
sampl
integr
build
effect
diagnosi
optic
mean
use
tradit
diagnosi
diseas
includ
malaria
giemsa
smear
ubiqu
optic
instrument
wide
rang
resolut
lens
angl
make
valuabl
tool
studi
monitor
diseas
progress
psalti
et
al
nonetheless
convent
optic
microscopi
bulki
expens
recent
howev
field
evolv
emerg
cheaper
optic
altern
enhanc
addon
wave
guid
creat
portabl
diagnost
hunt
wilkinson
chargecoupl
devic
ccd
base
platform
ozcan
demirci
develop
monitor
cell
particl
movement
shadow
imag
without
fluoresc
imag
detect
mode
includ
absorb
chemiluminesc
interferometr
myer
lee
instanc
juul
et
al
made
use
combin
dna
cleavagelig
event
droplet
microfluid
malaria
parasit
enzym
activ
detect
microfluid
platform
oper
detect
limit
less
unprocess
blood
juul
et
al
mobil
phone
also
function
imag
platform
also
employ
imag
thick
thin
giemsastain
smear
p
falciparum
irbc
brightfield
mount
light
microscop
breslauer
et
al
recent
horn
et
al
describ
paper
cartridg
coupl
autom
imag
process
softwar
detect
malaria
parasit
horn
et
al
cartridg
consist
thin
thick
smear
region
speci
identif
limit
detect
enhanc
respect
fig
two
main
way
advanc
optic
studi
tie
microfluid
studi
detect
malaria
firstli
emerg
cheaper
portabl
optic
instrument
use
observ
cellular
interact
microfluid
optic
microscopi
combin
microfluid
enhanc
onchip
detect
rbc
deform
chang
specif
diseas
regard
kim
et
al
creat
minimicroscop
insitu
monitor
cell
modifi
offtheshelf
compon
commerci
webcam
comparison
imag
cell
taken
inhous
microscop
convent
microscop
reveal
magnif
former
compar
object
len
approxim
magnif
afford
yet
power
optic
tool
facilit
emerg
cheap
optic
detect
secondari
speckl
sens
microscopi
cojoc
et
al
secondli
optic
also
combin
microfluid
investig
cellular
biophys
properti
differenti
cell
differ
type
state
adamo
et
al
gossett
et
al
lee
et
al
design
subpixel
resolv
optofluid
microscop
srofm
made
use
redgreenblu
rgb
led
captur
separ
color
imag
irbc
subsequ
combin
obtain
fulli
color
high
resolut
imag
team
stain
irbc
toluidin
blue
srfom
achiev
imag
resolut
highest
acuiti
method
circumv
sampl
prepar
fixat
unlik
convent
microscop
detect
method
howev
srfom
share
similar
limit
microscop
techniqu
unabl
identifi
ring
stage
irbc
limit
use
earli
malaria
detect
erdman
kain
potenti
optofluid
techniqu
use
detect
diseas
may
applic
malaria
also
deserv
highlight
ji
et
al
construct
microfluid
cytomet
found
transmiss
intens
differ
cell
type
differ
ji
et
al
lee
colleagu
also
introduc
idea
optic
pressur
detect
cancer
cell
lee
et
al
concept
may
adapt
malaria
diagnosi
potenti
use
magnet
microfluid
malaria
diagnosi
also
discuss
although
extens
literatur
report
paul
et
al
report
irbc
behav
like
paramagnet
particl
magnet
field
paul
et
al
motiv
research
use
magnet
mean
identifi
irbc
bhakdi
et
al
zimmerman
colleagu
propos
idea
use
magnet
concentr
irbc
enhanc
sensit
microscop
method
detect
malaria
zimmerman
et
al
nam
et
al
design
microfluid
devic
capit
magnet
properti
accumul
hemozin
irbc
separ
irbc
malaria
cultur
fe
hemozin
stronger
paramagnet
effect
fe
hemoglobin
nam
et
al
team
incorpor
nickel
wire
microfluid
devic
creat
steep
magnet
gradient
achiev
ring
stage
irbc
recoveri
rate
fig
nonetheless
devic
work
flow
rate
team
also
yet
show
creation
homogen
magnet
field
addit
concentr
hemozin
may
skew
number
parasit
ie
singlet
doublet
triplet
malleret
et
al
irbc
may
decreas
specif
microfluid
devic
inform
user
sever
stage
malaria
aforement
amount
hemozin
also
lower
ring
stage
irbc
low
parasitemia
level
pose
yet
anoth
challeng
earli
malaria
detect
peng
et
al
recent
made
use
magnet
reson
relaxometri
detect
hemozin
irbc
peng
et
al
new
approach
detect
whole
blood
may
adapt
microfluid
devic
use
portabl
magnet
radiofrequ
detect
probe
sepsi
seriou
lifethreaten
complic
due
infect
character
wholebodi
inflammatori
state
call
system
inflammatori
respons
syndrom
sir
occur
due
chemic
secret
fight
infect
levi
et
al
inflamm
overwhelm
blood
cleans
capac
organ
protect
function
immun
cell
hotchkiss
karl
sever
studi
publish
literatur
reader
interest
sepsi
caus
diagnosi
prognosi
strongli
suggest
read
articl
hotchkiss
karl
lever
mackenzi
sepsi
lead
multipl
organ
failur
shock
death
instanc
mortal
rise
everi
hour
delay
administ
antibiot
septic
shock
kumar
et
al
therefor
earli
fast
accur
diagnosi
treatment
sepsi
paramount
signific
current
diagnost
therapeut
approach
physic
examin
analysi
blood
urin
molecular
diagnost
techniqu
unless
integr
suboptim
besid
due
drawback
like
high
sampl
volum
requir
time
labor
intens
method
compliant
assur
criteria
ritzilehnert
su
et
al
extens
review
stateoftheart
bacteria
detect
look
specif
molecular
techniqu
appli
sepsisinfect
manag
su
et
al
innov
facilit
sepsi
manag
categor
review
two
broad
categori
diagnosi
ie
detect
pathogen
monitor
biochem
composit
patient
bodili
fluid
ii
treatment
sepsi
syndrom
identif
difficult
clinic
sign
septicemia
similar
lethal
diseas
includ
high
bodi
temperatur
difficulti
breath
abdomin
pain
abnorm
heart
pump
function
edmond
zaidi
escherichia
e
coli
common
caus
earlyonset
sepsi
neonat
camachogonzalez
et
al
recent
differ
approach
present
research
detect
e
coli
instant
method
magnet
separ
fluoresc
stain
electr
detect
microfluid
immunoassay
use
captur
identifi
e
coli
blood
yang
li
wang
et
al
fig
golden
et
al
develop
multi
wavelength
microflow
cytomet
use
groov
microfluid
channel
e
coli
assay
perform
demonstr
capabl
devic
discrimin
particl
golden
et
al
bisceglia
et
al
also
util
dep
microfluid
devic
isol
e
coli
bisceglia
et
al
chip
reduc
diagnosi
time
bypass
bacteria
cultur
howev
work
desir
reduc
process
time
hour
min
use
highli
dilut
blood
kang
colleagu
integr
expertis
dnazymebas
sensor
droplet
encapsul
particl
count
system
creat
comprehens
droplet
digit
detect
ic
system
fig
kang
et
al
platform
detect
low
e
coli
bacterium
dilut
blood
sampl
cultureamplificationfre
process
schwartz
bercovici
leverag
isotachophoresi
fluoresc
label
antimicrobi
peptid
continu
remov
e
coli
suspend
water
schwartz
bercovici
technolog
may
potenti
appli
detect
bacteria
bodili
fluid
especi
earli
sepsi
onset
sepsi
suspect
identifi
strain
sepsiscaus
bacteria
guid
therapeut
intervent
recent
patterson
et
al
report
novel
microfluid
chipbas
detect
strain
discrimin
microbi
pathogen
particularli
salmonella
serovar
deriv
whole
blood
septic
mice
patterson
et
al
mahalanabi
et
al
also
creat
microfluid
base
detect
system
cell
lysi
dna
extract
gramposit
gramneg
bacteria
known
caus
sepsi
may
coupl
pcr
construct
mahalanabi
et
al
improv
version
would
creat
capabl
differenti
even
bacteria
strain
within
gram
famili
stmicroelectron
mobidiag
unveil
labonchip
system
dnabas
detect
ten
sepsiscaus
bacteria
well
methicillinresist
strain
staphylococcu
aureu
posit
blood
cultur
sampl
similarli
hou
et
al
also
made
use
spiral
inerti
microfluid
techniqu
isol
differ
strain
bacteria
number
low
hou
et
al
fig
platform
also
coupl
rna
detect
profil
antibiot
resist
pathogen
make
use
mannos
bind
lectin
mbl
coat
magnet
bead
subsequ
magnet
flux
concentr
cooper
et
al
abl
spread
captur
candida
c
albican
fungi
thinli
optim
optic
imag
cooper
et
al
wang
et
al
argu
also
import
differenti
live
dead
bacteria
prevent
unnecessari
administr
antibiot
chang
et
al
group
thu
design
microfluid
system
base
ethidium
monoazidebas
assay
pcr
probe
live
bacteria
fluid
isol
periprosthet
joint
infect
sever
group
also
capit
biochem
composit
septic
patient
diagnost
monitor
evid
show
excess
nitric
oxid
product
play
key
role
cardiovascular
manifest
sever
sepsi
septic
shock
boveri
et
al
hunter
colleagu
fabric
amperometr
nitric
oxid
microfluid
sensor
low
background
nois
monitor
chang
blood
level
potenti
biomark
onset
sepsi
configur
enabl
rapid
analysi
small
sampl
volum
hunter
et
al
convent
system
antibiot
suscept
test
often
long
h
time
treatment
sepsi
studi
choi
cowork
introduc
microfluid
base
system
reduc
antimicrobi
suscept
test
ast
assay
time
determin
minim
inhibitori
concentr
singl
bacteri
time
laps
imag
choi
et
al
schotter
et
al
also
report
incorpor
magnet
marker
magnetoresist
sensor
appli
microfluid
devic
cytokinebas
diagnosi
sepsi
van
der
wouden
et
al
one
potenti
complic
diagnost
method
increas
product
cytokin
could
trigger
diseas
necessarili
respons
sepsi
furthermor
individu
like
differ
norm
level
minim
inhibitori
concentr
ast
may
make
diagnost
techniqu
becom
expens
due
need
establish
person
referencestandard
sepsi
associ
system
intravascular
activ
coagul
aird
use
learn
spatial
distribut
locat
tissu
factor
tf
geometri
vasculatur
regul
coagul
shen
et
al
develop
microfluid
system
surfac
phospholipid
bilay
pattern
tf
demonstr
experiment
threshold
respons
initi
coagul
size
shape
surfac
present
tf
shen
et
al
thermal
injuri
trigger
inflammatori
cascad
herald
shock
sir
even
death
davignon
et
al
address
prognost
diagnost
signific
chemotaxi
burn
injuri
microfluid
devic
exploit
measur
neutrophil
direct
migrat
speed
respons
chemoattract
gradient
establish
respons
infect
butler
et
al
use
assay
butler
et
al
establish
refer
set
migrat
speed
valu
neutrophil
healthi
subject
comparison
sampl
burn
patient
boneschansk
et
al
also
quantifi
leukocyt
migrat
pattern
chemoattract
repuls
kinesi
inhibit
use
microfluid
devic
differ
chemokin
ad
boneschansk
et
al
group
extens
quantifi
persist
speed
migrat
differ
dosag
receptor
express
base
knowledg
bacteria
rigid
cell
wall
withstand
harsher
chemic
treatment
compar
blood
cell
zelenin
colleagu
also
introduc
select
blood
cell
lysi
sampl
prepar
strategi
continu
isol
microorgan
whole
blood
downstream
analysi
zelenin
ramachandraiah
et
al
method
use
sampl
prepar
unit
molecularbas
poc
sepsi
diagnost
li
et
al
also
abl
enrich
aureu
fold
use
agaros
gel
permeabl
water
bacteria
li
et
al
devic
also
clinic
valid
facilit
sampl
prepar
rapid
sensit
manner
current
method
sepsi
diagnost
base
cellular
molecular
analysi
bodili
fluid
time
consum
costli
less
sensit
imped
time
clinic
intervent
microfluid
tool
develop
target
variou
stage
sepsi
provid
comprehens
pictur
diseas
instanc
microfluid
tool
quickli
identifi
infect
offer
highli
sensit
bacteri
isol
e
coli
undilut
blood
sampl
less
hour
also
microfluid
platform
develop
monitor
sepsi
progress
monitor
biochem
chang
patient
bodi
induc
sepsi
furthermor
microfluid
tool
provid
inform
antibiot
suscept
possibl
mix
infect
also
creat
guid
septic
treatment
microfluid
techniqu
facilit
faster
sensit
cheaper
way
target
differ
stage
sepsi
infect
progress
mix
infect
antibiot
resist
etc
guid
clinic
intervent
nonetheless
key
challeng
understand
limit
differ
diagnost
techniqu
possibl
integr
capabl
creat
platform
provid
bacterialfungi
strain
identif
ast
assay
high
sensit
b
bacteriaml
time
min
manner
current
sepsi
treatment
usual
involv
antibiot
therapi
patient
critic
condit
start
antibiot
treatment
immedi
even
test
result
identifi
bacteria
strain
come
back
laboratori
yung
et
al
complex
variabl
sepsi
devast
patient
antibioticresist
b
ic
system
enrich
bacteria
subsequ
detect
fluoresc
intens
bacteria
encapsul
singl
droplet
togeth
bacteriaspecif
dnazym
platform
coupl
optic
imag
differ
speci
bacteria
differenti
fluoresc
intens
henc
guid
therapeut
intervent
reprint
permiss
kang
et
al
c
spiral
microfluid
devic
make
use
dean
drag
forc
focu
bacteria
platelet
outer
wall
rbc
leukocyt
experi
substanti
inerti
lift
forc
focu
near
inner
wall
filtrat
devic
take
min
process
min
whole
blood
recoveri
pathogen
could
use
downstream
rna
analys
reprint
permiss
hou
et
al
blood
cleans
devic
remov
microorgan
bodi
artifici
biospleen
mimick
structur
role
spleen
contamin
blood
contain
magnet
opsonin
pass
microfluid
channel
high
flow
rate
extern
magnet
use
remov
pathogen
bound
magnet
element
discard
cleans
blood
return
subject
rat
process
activ
complement
cascad
coagul
reduc
amount
inflammatori
cytokin
system
reprint
permiss
kang
et
al
e
microfluid
devic
make
use
margin
remov
bacteria
less
deform
rbc
transvers
side
channel
caus
margin
bacteria
leukocyt
peripher
outlet
well
leav
center
outlet
bacteriafre
reprint
permiss
hou
et
al
f
massiv
parallel
arrang
straight
channel
util
inerti
microfluid
filtrat
bacteria
flow
rate
pathogen
deplet
effici
achiev
two
cycl
process
reprint
permiss
mach
di
carlo
pathogen
lack
effect
drug
kang
et
al
extracorpor
blood
purif
ie
hemofiltr
suggest
gotloib
et
al
use
septic
lung
injuri
result
remov
inflammatori
mediat
gotloib
et
al
novel
theori
propos
order
explain
benefici
effect
highvolum
hemofiltr
hvhf
sever
sepsi
system
inflammatori
respons
syndrom
sir
therapi
although
hypothesi
remain
subject
signific
debat
bouman
gener
univers
consensu
compon
blood
remov
better
clinic
outcom
address
root
problem
extracorpor
blood
cleans
therapi
rapidli
remov
microorgan
endotoxin
blood
propos
xia
colleagu
xia
et
al
use
simpl
microfluid
system
shown
success
remov
live
e
coli
bacteria
bound
magnet
nanoparticl
solut
contain
densiti
red
blood
cell
similar
found
blood
team
enhanc
throughput
system
use
multiplex
version
earlier
design
bacteria
captur
effici
flow
rate
mlh
singl
pass
yung
et
al
recent
group
came
anoth
design
made
use
magnet
bead
coat
mbl
cleans
blood
bacteria
fungi
endotoxin
without
activ
complement
cascad
coagul
fig
e
coli
aureu
reportedli
deplet
also
help
reduc
immun
cell
respons
inflamm
kang
et
al
nonetheless
one
main
concern
use
techniqu
lack
full
understand
nanotox
induc
magnet
nanoparticl
biocompat
coat
nanoparticl
degrad
time
expos
healthi
cell
toxic
free
metal
ion
core
furthermor
method
use
low
flow
rate
mlh
order
achiev
high
bacteri
captur
effici
averag
bodi
normal
hous
ml
blood
extracorpor
blood
cleans
procedur
ml
would
requir
h
may
infeas
implement
continu
due
easi
bubbl
format
clog
microfluid
channel
use
concept
inerti
microfluid
straight
microchannel
di
carlo
team
develop
massiv
parallel
microfluid
devic
passiv
separ
pathogen
bacteria
cell
dilut
blood
hematocrit
flow
rate
around
mlh
remov
effici
fig
mach
di
carlo
addit
margin
natur
phenomenon
leukocyt
move
toward
side
blood
vessel
goldsmith
spain
inspir
novel
method
treat
sepsi
instanc
base
margin
phenomenon
highthroughput
labelfre
microfluid
blood
filtrat
techniqu
microbi
remov
whole
blood
introduc
hou
et
al
demonstr
high
remov
effici
e
coli
cerevisia
pathogen
respect
recent
team
report
success
remov
pathogen
murin
model
sepsi
flow
rate
mlh
use
parallel
platform
demonstr
feasibl
system
blood
cleanser
clinic
set
fig
hou
et
al
aforement
huge
issu
use
microfluid
channel
possibl
clog
especi
whole
blood
natur
coagul
filter
addit
techniqu
offer
high
throughput
hundr
mlh
still
insuffici
character
effect
high
shear
forc
integr
rbc
potenti
immun
activ
leukocyt
summari
septic
blood
cleans
use
microfluid
platform
clinic
use
must
abl
perform
blood
cleans
higher
flow
rate
rang
mlmin
human
patient
much
larger
volum
blood
murin
model
understand
effect
shear
forc
endotheli
cell
line
vessel
wall
rbc
leukocyt
also
necessari
pursu
higher
bacteri
isol
effici
danger
microfluid
platform
may
propag
spread
bacteria
patient
bodi
addit
platform
gener
lack
comprehens
longterm
character
immun
respons
potenti
debri
microfluid
substrat
materi
use
magnet
bead
hiv
affect
million
individu
worldwid
affect
patient
live
develop
nation
need
assur
diagnost
antiretrovir
therapi
art
monitor
platform
unaid
hiv
infect
aid
broad
term
describ
rang
symptom
caus
retroviru
fauci
retroviru
primarili
transmit
host
via
fluid
exchang
sexual
contact
contamin
needl
horizont
epidem
also
spread
infect
mother
child
vertic
epidem
despit
lack
obviou
sign
infect
individu
actual
undergo
continu
loss
cell
eventu
crippl
immun
system
allow
patient
succumb
opportunist
infect
eg
pneumonia
later
stage
term
aid
dalgleish
et
al
current
establish
cure
hiv
infect
sever
antiretroviru
drug
shown
efficaci
suppress
latestag
symptom
onset
deek
et
al
drug
effect
diseas
detect
earlier
stage
kitahata
et
al
hiv
infect
lower
number
immun
cell
tlymphocyt
art
viru
replic
suppress
lead
gradual
increas
tlymphocyt
simon
ho
therefor
enumer
tlymphocyt
hiv
viral
load
use
diagnost
prognosi
purpos
typic
effect
clinic
applic
around
hiv
virusml
need
detect
whole
blood
lee
et
al
current
strategi
diseas
detect
includ
measur
viral
load
ogorman
gelman
determin
cell
count
ho
et
al
blood
oral
fluid
convent
techniqu
polymeras
chain
reaction
pcr
run
western
blot
rapid
limit
inabl
detect
low
viral
load
gradual
fluctuat
cell
count
especi
earli
stage
symptomless
hiv
infect
infant
within
year
old
rapid
antibodi
assay
also
suffici
valid
presenc
hiv
infect
due
persist
matern
antibodi
kellerman
essaje
shafie
et
al
comprehens
review
hiv
diseas
diagnost
also
manag
review
present
stateoftheart
hiv
diagnost
technolog
lymphocyt
count
viral
load
measur
drug
resist
test
highlight
role
microfluid
hiv
shafie
et
al
current
immunecaptur
cell
preval
method
cheng
cowork
made
use
cell
affin
chromatographi
antibodi
function
microchannel
surfac
control
shear
stress
isol
lymphocyt
whole
blood
hiv
diagnosi
cheng
et
al
differenti
surfac
express
size
influenc
cell
bind
antibodyfunction
surfac
allow
lymphocyt
monocyt
differenti
platform
specif
regard
lymphocyt
versu
monocyt
captur
perform
detect
less
min
howev
platform
reli
heavili
coat
antibodi
microchannel
surfac
lack
technolog
strict
qualiti
control
reproduc
wellcoat
platform
antibodi
may
compromis
furthermor
orient
lymphocyt
flow
microchannel
may
expos
coat
surfac
thu
reduc
diagnost
sensit
group
integr
immuneaffin
antibodi
function
surfac
autom
imag
quantifi
cell
count
alyassin
et
al
develop
microfluid
platform
coupl
autom
optic
imag
abl
perform
lymphocyt
count
time
faster
manual
count
alyassin
et
al
fig
design
softwar
abl
account
uneven
background
overlap
cell
imag
detect
cell
multipl
stain
offer
great
flexibl
hiv
detect
kim
colleagu
also
made
use
optim
imag
quantum
dot
identifi
hiv
duallabel
quantum
dot
abl
recogn
extern
envelop
protein
high
mannos
glycan
lowest
dilut
limit
high
sensit
ramachandraiah
cowork
made
use
centrifug
microfluid
function
cd
platform
autom
count
lymphocyt
use
microscop
ramachandraiah
et
al
wang
et
al
also
develop
melisa
detect
cell
unprocess
blood
step
elisa
spatial
confin
cellphon
use
quantifi
number
cell
overcom
potenti
loss
signal
chin
et
al
capit
effect
reduct
silver
ion
onto
gold
nanoparticl
sia
et
al
meander
channel
signal
amplif
chin
et
al
fig
fullyfunct
mchip
requir
unprocess
blood
hiv
syphili
diagnosi
near
sensit
specif
microfluid
platform
integr
imag
capabl
facilit
autom
diagnost
result
subject
user
interpret
bias
howev
make
integr
platform
access
develop
nation
much
higher
hiv
infect
rate
imag
compon
must
cheap
portabl
like
cellphon
base
system
wang
et
al
develop
yet
compar
spatial
resolut
sensit
song
cowork
present
methodolog
improv
speed
elisa
assay
bypass
block
step
keep
limit
detect
convent
elisa
song
et
al
recent
work
present
group
laksanasopin
et
al
full
laboratori
immunoassay
run
smartphon
accessori
use
microfluid
technolog
miniatur
hardwar
phone
accessori
incorpor
aforement
elisa
assay
use
power
gener
phone
perform
test
dilut
blood
sampl
ad
cassett
insert
dongl
absorb
read
level
silver
precipit
perform
min
later
result
marker
display
smartphon
interfac
devic
perform
assay
sensit
specif
watkin
et
al
develop
biochip
lymphocyt
count
base
differenti
electr
imped
watkin
et
al
fig
whole
blood
introduc
rbc
lyse
leav
supposedli
pure
popul
white
blood
cell
target
lymphocyt
flow
microfluid
channel
gener
spike
imped
amplitud
width
proport
size
transloc
veloc
block
flow
current
lymphocyt
count
close
match
result
flow
cytomet
rang
entir
process
perform
min
techniqu
howev
requir
chip
lysi
may
also
lyse
target
cell
nonspecif
gener
lysi
debri
caus
clog
interfer
readout
author
also
demonstr
spike
imped
caus
rbc
escap
lyse
avoid
nospecif
readout
glynn
et
al
specif
isol
magnet
tag
cell
directli
patient
blood
glynn
et
al
lowcost
dispos
microfluid
chip
oper
dualforc
cell
magnetophoresi
wherebi
interplay
flow
magnet
field
govern
trajectori
target
cell
depend
whether
cell
bound
magnet
microbead
instrumentfre
pump
implement
fingeractu
elast
membran
tag
bead
later
deflect
small
reusabl
perman
magnet
use
nanoparticl
enhanc
sensit
techniqu
compar
antibodi
function
microchannel
surfac
nanoparticl
smaller
capabl
bind
target
lymphocyt
although
method
made
cheaper
without
use
instrument
gener
flow
fingeractu
pressur
may
gener
steadi
flow
make
diagnost
result
nonreproduc
nonetheless
common
limit
techniqu
need
blood
lysi
also
lyse
target
lymphocyt
creat
cell
debri
lead
microchannel
clog
furthermor
microfluid
platform
tend
reli
antibodi
hiv
detect
know
hiv
progress
influenc
express
tlymphocyt
trial
et
al
nonspecif
bind
antibodi
anderson
et
al
key
paramet
specif
limit
detect
advers
affect
overcom
heavi
relianc
antibodi
lee
et
al
thu
develop
dispos
polym
revers
transcriptas
rt
pcr
chemiluminesc
assay
hiv
diagnost
constraint
limit
antibodi
use
fig
primer
target
major
core
protein
util
biochip
platform
perform
diagnosi
less
hour
supposedli
accur
use
antibodi
howev
devic
highli
unstabl
rna
current
isol
extern
may
introduc
inconsist
contamin
due
technician
skill
worth
explor
possibl
onchip
rna
isol
amplif
discuss
section
molecular
analysi
malaria
diagnosi
emerg
hiv
diagnost
method
nanoplasmon
detect
inci
et
al
nanostructur
photon
crystal
shafie
et
al
may
also
integr
microfluid
use
resourcescarc
commun
diagnost
need
nonetheless
describ
technolog
advanc
hiv
manag
least
develop
region
remain
major
challeng
expens
bulki
machin
need
readout
summari
unlik
malaria
sepsi
irbc
bacteria
isol
base
physic
properti
respect
hiv
virus
small
isol
use
microfluid
devic
therefor
current
techniqu
microfluid
diagnost
hiv
depend
highli
use
antibodi
target
lymphocyt
howev
hiv
stage
progress
reduc
specif
bind
furthermor
target
lymphocyt
flow
microchannel
due
unsteadi
flow
rate
differenti
cell
size
may
orient
properli
expos
antibodi
coat
microchannel
henc
reduc
diagnost
sensit
cost
antibodi
coat
also
prohibit
antibodi
solut
usual
use
excess
creat
issu
irreproduc
manufactur
dnarna
base
techniqu
circumv
problem
antibodi
relianc
offer
higher
sensit
specif
group
yet
creat
fulli
integr
system
free
user
skill
bias
nonetheless
interest
group
learn
research
malaria
field
onchip
nucleic
acid
isol
amplif
demonstr
sar
caus
new
coronaviru
cov
start
spread
around
world
outbreak
sar
eventu
control
manag
strategi
isol
suspect
close
contact
due
absenc
effect
cure
sar
claim
live
mainli
asianpacif
region
hui
et
al
convent
mean
includ
determin
antibodi
level
isol
sar
viru
employ
diagnosi
nonetheless
antibodi
level
start
increas
day
infect
cell
cultur
sar
viru
tediou
timeconsum
zhou
et
al
zhou
et
al
creat
diagnost
platform
sarscov
via
multiplex
real
time
rt
pcr
capillari
electrophoresi
integr
microfluid
chip
system
abl
provid
posit
result
clinic
diagnos
sar
patient
convent
rtpcr
agaros
gel
electrophoresi
gave
posit
result
zhou
et
al
huh
et
al
also
develop
microfluid
platform
integr
magnet
forceactiv
micromix
system
function
surfac
cell
lysi
purif
intracellular
protein
sarscov
detect
choi
et
al
similarli
ramalingan
colleagu
made
use
isotherm
helicasedepend
amplif
method
detect
sar
viru
dna
integr
microfluid
pcr
chip
ramalingam
et
al
similar
hiv
sar
caus
viru
limit
techniqu
diagnosi
hiv
virus
difficult
isol
current
microfluidicbas
diagnost
platform
sar
detect
platform
make
use
antibodi
sarscov
function
surfac
face
problem
nonspecif
bind
due
diseas
progress
reproduc
manufactur
function
surfac
antibodi
also
expens
use
excess
order
fulli
function
microchannel
surfac
increas
cost
microfluid
devic
make
less
access
patient
develop
nation
hand
nucleic
acidbas
method
offer
higher
sensit
specif
compar
antibodi
method
howev
latter
techniqu
requir
longer
diagnost
time
nucleic
acid
isol
amplif
must
also
precis
temperatur
control
effici
amplif
occur
may
add
manufactur
complex
diagnost
chip
respiratori
infecti
diseas
repres
one
largest
caus
death
dali
lost
yager
et
al
therefor
techniqu
area
immuneaffin
optic
encourag
appli
area
boost
diseas
diagnosi
dengu
viru
propag
mosquito
vector
major
infect
concentr
latin
america
asia
rigauperez
et
al
four
serotyp
dengu
viru
produc
mild
dengu
fever
sever
dengu
shock
syndrom
human
gubler
due
small
size
dengu
virus
main
diagnost
method
still
nucleic
acid
proteinserolog
base
clinic
test
dengu
hemagglutin
inhibit
neutral
nonspecif
prohibit
expens
tele
argu
thu
role
microfabr
devic
play
facilit
dengu
diagnosi
tele
reader
refer
extens
review
darwish
et
al
convent
mean
dengu
diagnost
darwish
et
al
su
colleagu
coat
two
surfac
immunochip
glycoprotein
nonstructur
protein
analyz
signal
piezotransducerlik
arrang
diagnos
dengu
kumbhat
et
al
util
surfac
plasmon
reson
diagnos
deposit
dengu
viru
increas
reson
angl
kumbhat
et
al
zaytseva
colleagu
made
use
fluoresc
liposom
conjug
report
probe
bind
dengu
viru
rna
diagnosi
zaytseva
et
al
weng
et
al
report
develop
microfluid
devic
function
antibodi
specif
dengu
viru
equip
suction
unit
creat
neg
pressur
transport
mix
fluid
weng
et
al
entir
durat
need
diagnosi
reduc
h
min
devic
similarli
gunda
colleagu
made
use
dengu
viru
bound
micropillar
improv
surfac
area
bind
subsequ
enhanc
detect
sensit
gunda
et
al
aeinehvand
team
incorpor
microballoon
mixer
expand
contract
centrifug
microfluid
platform
improv
sensit
elisa
detect
dengu
viru
due
improv
mix
aeinehvand
et
al
recent
zhang
colleagu
develop
multistack
paper
immunoassay
remov
proteinac
substanc
saliva
detect
target
antigen
adsorb
antibodi
zhang
et
al
devic
obviat
step
centrifug
boost
detect
denguespecif
immunoglobin
igg
serum
use
differenti
primari
secondari
infect
addit
diagnosi
also
effort
improv
understand
biolog
dengu
viru
instanc
huang
et
al
also
made
use
microfluid
devic
coupl
optic
measur
effect
carrageenan
inhibit
life
cycl
dengu
virus
group
measur
cellular
oxygen
consumpt
rate
ocr
reflect
cellular
metabol
rate
found
treatment
carrageenan
maintain
ocr
cell
indic
high
cell
viabil
technolog
also
applic
drug
screeningtox
rang
infecti
diseas
microfluid
devic
dengu
diagnosi
demonstr
higher
sensit
shorter
process
time
compar
convent
method
use
time
clinic
intervent
aforement
problem
antibodi
function
surfac
method
diagnost
one
key
limit
studi
microfluid
platform
differenti
differ
type
stage
dengu
infect
dengu
caus
differ
dengu
virus
addit
sever
diseas
greater
coinfect
reinfect
anoth
viru
henc
challeng
creat
microfluid
devic
use
clinic
dengu
diagnosi
offer
result
differenti
viru
strain
diseas
stage
estim
tuberculosi
claim
million
death
annual
although
larg
treatabl
diseas
larg
number
undiagnos
case
global
detect
prevent
time
therapeut
intervent
mcnerney
daley
reader
encourag
refer
review
dheda
et
al
comprehens
discuss
avail
diagnost
tool
liquid
cultur
smear
microscopi
xpert
mtbrif
assay
tuberculosi
dheda
et
al
convent
diagnost
mean
tuberculosi
face
limit
infecti
diseas
diagnosi
poor
specif
high
cost
larg
volum
sampl
need
mani
et
al
note
microfabr
devic
may
potenti
fill
gap
diagnost
effort
tuberculosi
instanc
wojcik
cowork
design
colorimetr
dna
test
base
conjug
gold
nanoparticl
coval
bound
gene
fragment
mycobacterium
tuberculosi
bernackawojcik
lee
et
al
b
design
stack
later
flow
paper
microfluid
assay
dengu
diagnost
saliva
patient
filter
paper
layer
made
fiber
glass
remov
proteinac
substanc
detect
sensit
ngml
saliva
serum
achiev
control
line
also
present
devic
posit
control
reprint
permiss
zhang
et
al
c
fulli
integr
thermoplast
microfluid
devic
detect
dna
tuberculosi
drug
resist
fluidic
path
control
electr
actuat
solenoid
step
cell
lysi
dna
isol
pcr
perform
fulli
microfluid
chip
micropillar
also
employ
enhanc
densiti
adsorb
dna
colorimetr
detect
reprint
permiss
wang
et
al
liong
et
al
team
describ
partial
integr
microfluid
platform
dna
tuberculosi
first
extract
extern
captur
onto
polymer
bead
complimentari
captur
dna
bead
coupl
probedna
bound
magnet
nanoparticl
render
mnpload
bead
paramagnet
paramagnet
mnpload
bead
produc
local
magnet
field
bead
load
differ
quantiti
tuberculosi
dna
produc
differ
decay
rate
subject
nuclear
magnet
reson
read
allow
diagnosi
perform
portabl
microfluid
devic
capabl
perform
onchip
loopmedi
isotherm
nucleic
acid
amplif
lamp
manual
inspect
also
design
fang
colleagu
tuberculosi
detect
h
fang
et
al
recent
labelfre
assay
detect
dna
tuberculosi
relat
drug
resist
design
et
al
platform
make
use
quantif
hydrat
induc
stress
microcantilev
function
oligonucleotid
probe
hybrid
specif
nucleic
acid
target
total
analysi
time
h
sensit
pgml
report
howev
describ
method
platform
fulli
integr
requir
offchip
process
step
nucleic
acid
extract
may
affect
reproduc
diagnost
result
due
skill
techniciansus
wang
cowork
thu
develop
fulli
integr
individu
chamber
cell
lysi
dna
isol
amplif
etc
microfluid
cartridg
interrog
singlebas
variat
codon
multidrug
resist
form
tuberculosi
wang
et
al
micropillar
also
use
enhanc
densiti
dna
adsorpt
enhanc
colorimetr
readout
platform
fulli
autom
prevent
user
bias
massproduc
made
thermoplast
ensur
product
qualiti
low
cost
dispos
use
onetim
use
potenti
infect
contamin
sampl
tuberculosiscaus
bacteria
isol
pleural
fluid
microfluid
devic
make
use
inerti
focus
dep
magnet
bead
describ
malaria
sepsi
diagnosi
use
technolog
strength
weak
describ
previou
section
use
refer
creat
microfluid
platform
tuberculosi
diagnosi
although
current
mani
microfluid
devic
creat
tuberculosi
diagnost
pointofcar
assay
may
potenti
integr
microfluid
make
use
masspiezoelectr
ren
et
al
optic
buijtel
et
al
enzymat
xie
et
al
acoust
techniqu
et
al
nanotechnolog
also
emerg
highli
use
tool
enhanc
sensit
signal
diagnost
result
vandan
et
al
howev
one
import
note
tuberculosi
larg
elimin
develop
nation
devic
mainli
target
develop
nation
low
cost
high
portabl
fig
tabl
commerci
develop
play
key
role
make
poc
technolog
access
resourcescarc
commun
tabl
show
list
microfluid
devic
diagnosi
variou
infecti
diseas
seen
tabl
commerci
technolog
either
antibodi
dna
primer
although
mean
diagnost
avail
platform
base
analyt
adapt
diagnos
wider
rang
diseas
instanc
platform
develop
micron
use
malaria
initi
expand
also
sepsi
greater
number
public
guid
innov
commerci
microfluid
technolog
chin
et
al
su
et
al
howev
challeng
deserv
highlight
innov
briefli
mention
two
financ
diagnost
target
resourcescarc
commun
price
low
competit
access
creat
pressur
profit
gener
may
appeal
privat
ventur
capitalist
therefor
like
compani
serv
develop
develop
nation
flourish
market
govern
philanthrop
foundat
bill
melinda
gate
help
commerci
poc
diagnost
resourcescarc
commun
expect
continu
play
signific
role
financ
integr
mention
earlier
section
variou
technolog
fluid
deliveri
mix
onchip
heat
cool
microfluid
pcr
combin
creat
function
product
anoth
exampl
acquisit
advanc
liquid
logic
special
electrowet
droplet
microfluid
illumina
molecular
diagnost
busi
arm
need
collabor
amongst
differ
team
even
compani
capit
one
anoth
expertis
convent
diagnost
tool
infecti
diseas
limit
long
process
time
high
cost
nonuserfriendli
technic
complex
poor
sensit
specif
microfluid
devic
demonstr
even
small
sampl
volum
abl
offer
high
accuraci
detect
cost
compat
averag
incom
resourcescarc
commun
mani
innov
idea
gener
malaria
diagnosi
use
dielectrophoret
properti
lower
deform
irbc
droplet
microfluid
also
integr
softwar
analyz
bacteria
contamin
sepsi
diagnost
tool
therapeut
equip
blood
cleans
devic
also
creat
advanc
microfabr
technolog
nonetheless
stress
diseas
sar
dengu
concentr
develop
nation
still
much
neglect
scientif
commun
develop
nation
govern
nongovernment
organ
philanthrop
foundat
play
import
role
financ
project
neglect
infecti
diseas
improv
made
addit
compani
commerci
poc
devic
also
face
challeng
rais
fund
privat
sector
due
target
market
resourcescarc
set
forese
mobil
technolog
play
key
role
togeth
microfluid
diagnost
devic
remot
health
monitor
especi
resourcescarc
region
healthcar
poorli
access
mind
electrochem
electr
imped
colorimetr
assay
much
use
mean
readout
use
cell
phone
believ
continu
effort
scientist
biomed
industri
develop
microfluid
technolog
benefit
million
peopl
disproportion
affect
infecti
diseas
